Stem Cell Therapy Platform
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
40
NCT02805023
BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI)
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jun 30, 2016
Completion: Dec 31, 2027
Loading map...